IOVA R&D Expense Growth
Iovance Biotherapeutics Inc · R&D Expense Growth
IOVA R&D Expense Growth
Latest reported6.35%period ending
IOVA FY R&D Growth (YoY) (0.00% → 6.35%)
Latest values, visible window
High-resolution chart · PNG
IOVA r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 6.352% | |
| -17.9439% | |
| 16.7229% | |
| 13.7979% | |
| 28.4107% | |
| 21.5055% | |
| 66.3091% | |
| 39.3954% | |
| 155.4303% | |
| 81.2346% | |
| 471.9039% | |
| 103.5365% | |
| -19.7464% | |
| -5.6948% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |